Developing Sales Channels with a View to Expanding Overseas Sales of Japanese-made Medical Equipment
First written in FY2018. 2 of 7 entries say "Advanced", first in FY2023-Q3. Latest entry: FY2025-H1.
6 other companies' latest entry also says "Advanced".
- FY2025-H1AdvancedAnnual report
「The company has been included in the scope of consolidation from the current interim consolidated accounting period.」
THAI OLBA Healthcare Co., Ltd. became subject to consolidation as the joint venture launched to sell medical equipment in Thailand grew in significance. - FY2024RestatedAnnual report
「We will promote the establishment of a business base in Thailand, the expansion of Kawanishi Barkmed's clinic-focused business, business alliances both within and outside the industry, investment in human capital, and initiatives that take the global environment into consideration.」
The Company continues to pursue its overseas expansion policy, including establishing a business base in Thailand, as part of the medium-term management plan's "Investment in the Future." - FY2023-Q3AdvancedAnnual report
「In addition, for the purpose of selling medical equipment mainly in Thailand, we entered into a JOINT BUSINESS AGREEMENT on 26 January 2023 with Thai individual shareholders concerning a joint investment in and operation of THAI OLBA Healthcare Co., Ltd. (formerly Medical Device Innovation Co., Ltd.), and commenced the joint venture business.」
The Company's overseas expansion progressed from exploring opportunities to enter ASEAN to the concrete step of launching a joint venture aimed at selling medical equipment in Thailand. - FY2022ReframedAnnual report
「Exploring opportunities to enter ASEAN countries」
Separately from its previous policy of developing domestic and overseas sales channels for Japanese-made medical devices, the Company identified specific overseas target markets by moving toward exploring opportunities to enter ASEAN countries as part of its revenue-source diversification efforts. - FY2020DroppedAnnual report
「以上を踏まえ、中長期的な方針として以下の８つを掲げています。」
The previously stated policy of developing sales channels with a view to supporting the domestic and overseas expansion of Japanese-made medical devices is not included among the 8 medium- to long-term policies this time. - FY2019RaisedAnnual report
「⑤ Activities to develop sales channels with a view to supporting the domestic and overseas expansion of Japanese-made medical devices」
The Company expanded the scope of its sales-channel development policy from its previous focus on supporting the overseas expansion of Japanese-made medical devices to explicitly include domestic expansion. - FY2018First statedAnnual report
「Activities to develop sales channels with a view to supporting the overseas expansion of Japanese-made medical devices」
The Company has for the first time explicitly stated its policy of developing sales channels with a view to supporting the overseas expansion of Japanese-made medical devices.